Literature DB >> 30104774

Tonsillar plasmacytoma in a dog.

Yoshimi Iwaki1, Colleen Monahan1, Rebecca Smedley1, David Upchurch1, Paulo Vilar-Saavedra1.   

Abstract

A 10-year-old greyhound dog was presented because of an incidental finding of a tonsillar mass. Excisional surgical biopsy was performed and the dog was diagnosed with an incompletely resected plasma cell tumor. Adjuvant therapy was declined. One year later there was no local recurrence or distant metastasis of the mass or clinical signs associated with the tonsillar plasmacytoma.

Entities:  

Mesh:

Year:  2018        PMID: 30104774      PMCID: PMC6049337     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  30 in total

1.  Uterine extramedullary plasmacytoma in a dog.

Authors:  Y K Choi; J Y Lee; D Y Kim; J I Park; S W Jeong; H M Park; C Park
Journal:  Vet Rec       Date:  2004-05-29       Impact factor: 2.695

2.  Bilateral extramedullary plasmacytomas of the palatine tonsils: a case report.

Authors:  E Y Hanna; P Lavertu; H M Tucker; R P Tubbs
Journal:  Otolaryngol Head Neck Surg       Date:  1990-12       Impact factor: 3.497

3.  Clinical features and prognostic factors in solitary plasmacytoma.

Authors:  Paola Finsinger; Sara Grammatico; Marta Chisini; Alfonso Piciocchi; Robin Foà; Maria T Petrucci
Journal:  Br J Haematol       Date:  2015-12-18       Impact factor: 6.998

4.  NCCN clinical practice guidelines in oncology: multiple myeloma.

Authors:  Kenneth C Anderson; Melissa Alsina; William Bensinger; J Sybil Biermann; Asher Chanan-Khan; Adam D Cohen; Steven Devine; Benjamin Djulbegovic; Cristina Gasparetto; Carol Ann Huff; Madan Jagasia; Bruno C Medeiros; Ruby Meredith; Noopur Raje; Jeffrey Schriber; Seema Singhal; George Somlo; Keith Stockerl-Goldstein; Guido Tricot; Julie M Vose; Donna Weber; Joachim Yahalom; Furhan Yunus
Journal:  J Natl Compr Canc Netw       Date:  2009-10       Impact factor: 11.908

5.  Clinical features, outcome, and prognostic factors for survival and evolution to multiple myeloma of solitary plasmacytomas: a report of the Greek myeloma study group in 97 patients.

Authors:  Eirini Katodritou; Evangelos Terpos; Argiris S Symeonidis; Anastasia Pouli; Charikleia Kelaidi; Marie-Christine Kyrtsonis; Maria Kotsopoulou; Sosana Delimpasi; Anna Christoforidou; Nikolaos Giannakoulas; Nora-Athina Viniou; Ekaterini Stefanoudaki; Christina Hadjiaggelidou; Dimitrios Christoulas; Evgenia Verrou; Vassiliki Gastari; Sofia Papadaki; Genovefa Polychronidou; Athina Papadopoulou; Evlambia Giannopoulou; Efstathios Kastritis; Alexandra Kouraklis; Pavlina Konstantinidou; Achilles Anagnostopoulos; Konstantinos Zervas; Meletios A Dimopoulos
Journal:  Am J Hematol       Date:  2014-05-12       Impact factor: 10.047

6.  Use of PET/CT and Stereotactic Radiation Therapy for the Diagnosis and Treatment of Osteosarcoma Metastases.

Authors:  Laura Elizabeth Selmic; Lynn R Griffin; Michael W Nolan; James Custis; Elissa Randall; Stephen J Withrow
Journal:  J Am Anim Hosp Assoc       Date:  2016-11-14       Impact factor: 1.023

7.  Progression of cutaneous plasmacytoma to plasma cell leukemia in a dog.

Authors:  Emily D Rout; Alba Maria M Shank; Angharad H K Waite; Andrea Siegel; Anne C Avery; Paul R Avery
Journal:  Vet Clin Pathol       Date:  2017-02-10       Impact factor: 1.180

8.  IRF-4,8 orchestrate the pre-B-to-B transition in lymphocyte development.

Authors:  Runqing Lu; Kay L Medina; David W Lancki; Harinder Singh
Journal:  Genes Dev       Date:  2003-06-27       Impact factor: 11.361

9.  Solitary extramedullary plasmacytoma of the canine larynx.

Authors:  A M Hayes; S P Gregory; S Murphy; J F McConnell; J C Patterson-Kane
Journal:  J Small Anim Pract       Date:  2007-04-08       Impact factor: 1.522

10.  Extramedullary plasmacytoma of the tonsil with nodal involvement.

Authors:  Simon Bazaadut; Dilshard Soodin; Pradeep Singh; Alhossain Khalafallah; Shannon Withers; Scott Taylor; Ruchira Fernando
Journal:  Int J Otolaryngol       Date:  2010-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.